The European biotechnology market is projected to grow at a significant CAGR of 6.9% during the forecast period. Next-generation sequencing (NGS), also known as high-throughput sequencing, is the catch-all term that is used to describe a number of different modern sequencing technologies such as Illumina (Solexa) sequencing, Roche 454 sequencing, Ion torrent: Proton / PGM sequencing, SOLiD sequencing and so on. These recent technologies allow us to sequence DNA and RNA much more quickly and cheaply than the previously used Sanger sequencing. Such technologies have therefore revolutionized the study of genomics and molecular biology. The advancements in NGS are driving the R&D programs across the region.
The rising lifestyle-oriented diseases such as CVD, CHD, Cancer, infectious diseases and so on are creating demand for NGS for the R&D process. Technological advancements have led to the introduction of NGS platforms in cancer investigation. NGS allows massive parallel sequencing that affords maximal tumor genomic assessment. NGS approaches are different, and concern DNA and RNA analysis. In recent years, NGS technologies have played a vital role in understanding the altered genetic pathway involved in human cancer. The fact that NGS has a high likelihood of producing results of unknown significance that it has attracted the researchers to explore the cancer disease.
To Request a Sample of our Report on European Biotechnology Market: https://www.omrglobal.com/request-sample/european-biotechnology-market
European Biotechnology Market – Segmentation
By Type
- Healthcare
- Crop Production and Agriculture
- Industrial
- Natural Resources & Environment
- Others (Bioinformatics)
A full Report of European Biotechnology Market is Available at: https://www.omrglobal.com/industry-reports/european-biotechnology-market
European Biotechnology Market – Segmentation by Geography
- UK
- Germany
- France
- Spain
- Italy
Rest of Europe
Company Profiles
- Abbott Laboratories
- AbbVie Inc.
- Alere Inc.
- Alkermes PLC
- Amgen Inc.
- AstraZeneca PLC
- Biogen Inc.
- Bristol-Myers Squibb Co.
- CSL Ltd.
- Hoffmann La-Roche Ltd.
- Johnson & Johnson Services Inc.
- Novartis AG
- Novo Nordisk A/S
- Pfizer Inc.
- Regeneron Pharmaceuticals, Inc.
- Sanofi SA
- Thermo Fisher Scientific Inc.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/european-biotechnology-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
